YCM
ANIK icon

Yousif Capital Management’s Anika Therapeutics ANIK Stock Holding History

Yousif Capital Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-7,962
Closed -$207K – 1982
2023
Q2 		$207K Sell
7,962
-368
-4% -$9.85K ﹤0.01% 1839
2023
Q1 		$239K Sell
8,330
-690
-8% -$20.5K ﹤0.01% 1780
2022
Q4 		$267K Sell
9,020
-2,585
-22% -$73.5K ﹤0.01% 1746
2022
Q3 		$276K Sell
11,605
-129
-1% -$2.97K ﹤0.01% 1716
2022
Q2 		$262K Sell
11,734
-1,165
-9% -$26K ﹤0.01% 1766
2022
Q1 		$324K Buy
12,899
+450
+4% +$13.7K ﹤0.01% 1775
2021
Q4 		$446K Buy
+12,449
New +$498K ﹤0.01% 1699

Other funds holding ANIK

TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Yousif Capital Management's ANIK Position: Q3 2023 in Review

Yousif Capital Management sold out of Anika Therapeutics (ANIK) in Q3 2023, closing a stake of 7,962 shares — an estimated $207K sold.

Yousif Capital Management first reported a position in ANIK in Q4 2021 and held it in 7 quarters. The position peaked at $446K in Q4 2021. 115 funds tracked by Wall St. Rank hold ANIK as of Q3 2023.

  • Yousif Capital Management reported no remaining Anika Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Yousif Capital Management sold 7,962 Anika Therapeutics shares in Q3 2023, an estimated $207K.
  • Yousif Capital Management first reported a position in Anika Therapeutics in Q4 2021 and held it in 7 quarters.
  • Yousif Capital Management's Anika Therapeutics position peaked at $446K in Q4 2021.
  • 115 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2023.

Based on Yousif Capital Management's 13F filing for Q3 2023, filed 30 Oct 2023.